This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comparative Study

. 2004 Aug;26(4):191-2.

doi: 10.1023/b:phar.0000035902.67235.5c.

Use of angiotensin receptor antagonists in patients with ACE inhibitor induced angioedema

Sabine A Fuchs¹, Ronald H B Meyboom, Eugène P van Puijenbroek, Henk-Jan Guchelaar

Affiliations

PMID: 15446773
DOI: 10.1023/b:phar.0000035902.67235.5c

Comparative Study

Use of angiotensin receptor antagonists in patients with ACE inhibitor induced angioedema

Sabine A Fuchs et al. Pharm World Sci. 2004 Aug.

. 2004 Aug;26(4):191-2.

doi: 10.1023/b:phar.0000035902.67235.5c.

Authors

Sabine A Fuchs¹, Ronald H B Meyboom, Eugène P van Puijenbroek, Henk-Jan Guchelaar

Affiliation

¹ Department of Pediatrics, University Medical Center Utrecht, Utrecht, The Netherlands.

PMID: 15446773
DOI: 10.1023/b:phar.0000035902.67235.5c

No abstract available

PubMed Disclaimer

Similar articles

Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
[No authors listed] [No authors listed] Prescrire Int. 2005 Oct;14(79):180-6. Prescrire Int. 2005. PMID: 16285075
Can angiotensin receptor antagonists be used safely in patients with previous ACE inhibitor-induced angioedema?
Howes LG, Tran D. Howes LG, et al. Drug Saf. 2002;25(2):73-6. doi: 10.2165/00002018-200225020-00001. Drug Saf. 2002. PMID: 11888349 Review.
Angioedema in heart failure: occurrence with ACE inhibitors and safety of angiotensin receptor blocker therapy.
Sica DA, Black HR. Sica DA, et al. Congest Heart Fail. 2002 Nov-Dec;8(6):334-41, 345. doi: 10.1111/j.1527-5299.2002.01529.x. Congest Heart Fail. 2002. PMID: 12461324 Review.
The role of angiotensin receptor blockers in patients with angiotensin-converting enzyme inhibitor-induced angioedema.
Beavers CJ, Dunn SP, Macaulay TE. Beavers CJ, et al. Ann Pharmacother. 2011 Apr;45(4):520-4. doi: 10.1345/aph.1P630. Epub 2011 Mar 22. Ann Pharmacother. 2011. PMID: 21427294 Review.
Life Threatening Angioedema Due to Valsartan/Sacubitril With Previously Well-Tolerated ACE Inhibitor.
Raheja H, Kumar V, Kamholz S, Hollander G, Shani J. Raheja H, et al. Am J Ther. 2018 Jul/Aug;25(4):e508-e509. doi: 10.1097/MJT.0000000000000600. Am J Ther. 2018. PMID: 28452844 No abstract available.

See all similar articles

Cited by

Pharmacoeconomics of angiotensin II antagonists in type 2 diabetic patients with nephropathy: implications for decision making.
Boersma C, Atthobari J, Gansevoort RT, de Jong-Van den Berg LT, de Jong PE, de Zeeuw D, Annemans LJ, Postma MJ. Boersma C, et al. Pharmacoeconomics. 2006;24(6):523-35. doi: 10.2165/00019053-200624060-00001. Pharmacoeconomics. 2006. PMID: 16761901 Review.
Bradykinin Metabolism and Drug-Induced Angioedema.
Smolinska S, Antolín-Amérigo D, Popescu FD. Smolinska S, et al. Int J Mol Sci. 2023 Jul 19;24(14):11649. doi: 10.3390/ijms241411649. Int J Mol Sci. 2023. PMID: 37511409 Free PMC article. Review.
Economic evaluations of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in type 2 diabetic nephropathy: a systematic review.
Huang Y, Zhou Q, Haaijer-Ruskamp FM, Postma MJ. Huang Y, et al. BMC Nephrol. 2014 Jan 15;15:15. doi: 10.1186/1471-2369-15-15. BMC Nephrol. 2014. PMID: 24428868 Free PMC article.
Angiotensin-converting enzyme inhibitor-induced angioedema: A review of the literature.
Brown T, Gonzalez J, Monteleone C. Brown T, et al. J Clin Hypertens (Greenwich). 2017 Dec;19(12):1377-1382. doi: 10.1111/jch.13097. Epub 2017 Oct 10. J Clin Hypertens (Greenwich). 2017. PMID: 28994183 Free PMC article. Review.

References

1. Arch Intern Med. 1998 Oct 12;158(18):2063-5 - PubMed
1. Hypertension. 1998 Jan;31(1 Pt 2):349-55 - PubMed
1. Annu Rev Pharmacol Toxicol. 1996;36:281-306 - PubMed
1. Drug Saf. 1998 Mar;18(3):171-88 - PubMed
1. Ann Pharmacother. 2000 Apr;34(4):526-8 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
Miscellaneous
- NCI CPTAC Assay Portal